Development of a Novel AAV-Mediated microRNA Gene Therapy for Spatial Suppression of BACE1 to Improve Cognitive Function in Alzheimer’s Disease Model Mice
Biomolecules · 23.07.2026 · 16 (8) · 1075
DOI: 10.3390/biom16081075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 23.07.2026. Verfasst von Ying Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, China. Hauptthemen laut MEDLINE: MicroRNAs, Alzheimer Disease, Amyloid Precursor Protein Secretases, Aspartic Acid Endopeptidases. Die Arbeit nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fujian Provincial Department of Science and Technology, the Natural Science Foundation of Fujian Province.
Themen: Demenz
Abstract (Originalsprache)
The beta-site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1) is a promising and rational target for Alzheimer’s disease (AD), but current clinical trials have been disappointing. Consequently, utilizing the intrinsic regulatory mechanisms of BACE1 during AD pathogenesis might provide valuable insights into the treatment of this devastating disease. In this study, we proposed a combination of AAV delivery and microRNA therapeutics targeting AD at its root by sustained and spatial inhibition of BACE1 with a single therapeutic injection. We demonstrate that upregulation of BACE1 is correlated with downregulation of miR-143-3p in the hippocampus of individuals with AD, and miR-143-3p can directly target BACE1 to inhibit Aβ generation. In the brains of 5×FAD model mice, BACE1 levels are found to be elevated with age in the cornu ammonis 1 (CA1) subfield of the hippocampus. AAV-mediated miR-143-3p restoration in the hippocampal CA1 subfield of AD mice can improve cognitive performance, attenuate BACE1 expression, reduce Aβ levels, induce microglia polarization toward the anti-inflammatory phenotype, modulate neural-related genes including Gal3, and promote synaptic functions. Collectively, the AAV-mediated microRNA gene therapy approach developed for spatial suppression of BACE1 can effectively enhance cognitive performance in AD model mice, offering an attractive therapeutic option for AD treatment with long-lasting efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, China.
- Fujian Key Laboratory of Cognitive Function and Diseases, Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, Institute of Basic Medicine, School of Basic Medical Sciences, Fujian Medical Uni…
- Key Laboratory of Non-Coding RNA and Drug Discovery, School of Basic Medical Sciences, Chengdu Medical College, Chengdu 610500, China.
- School of Basic Medical Sciences, Ningxia Medical University, Yinchuan 750004, China.
ORCID-Profile: Tae Ho Lee
Förderung
- National Natural Science Foundation of China
- Fujian Provincial Department of Science and Technology
- the Natural Science Foundation of Fujian Province
- oint Funds for the Innovation of Science and Technology, Fujian Province
Zitieren
APA
Zhou, Y., Diao, Y., Yan, Z., Shui, X., Huang, Z., Sun, Y., Wang, S., Xia, Y., Lee, T. H., & Wang, L. (2026). Development of a Novel AAV-Mediated microRNA Gene Therapy for Spatial Suppression of BACE1 to Improve Cognitive Function in Alzheimer’s Disease Model Mice. Biomolecules, 16(8), 1075. https://doi.org/10.3390/biom16081075
Vancouver
Zhou Y, Diao Y, Yan Z, Shui X, Huang Z, Sun Y, et al. Development of a Novel AAV-Mediated microRNA Gene Therapy for Spatial Suppression of BACE1 to Improve Cognitive Function in Alzheimer’s Disease Model Mice. Biomolecules. 2026;16(8):1075. doi:10.3390/biom16081075
BibTeX
@article{Zhou2026,
author = {Zhou, Ying and Diao, Yuelin and Yan, Zhexiao and Shui, Xindong and Huang, Zichen and Sun, Yan and Wang, Siyao and Xia, Yanqing and Lee, Tae Ho and Wang, Long},
title = {Development of a Novel AAV-Mediated microRNA Gene Therapy for Spatial Suppression of BACE1 to Improve Cognitive Function in Alzheimer’s Disease Model Mice},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {8},
pages = {1075},
doi = {10.3390/biom16081075}
}
EUVIMED